APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Formulary Management

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Formulary Management Market Analysis and Forecast 2026-2032

6 March 2026190 pages

Choose your research edition.

Industry ResearchDrug Formulary Management Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Formulary Management Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Drug Formulary Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Formulary Management Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Formulary Management Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Drug Formulary Management market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Formulary Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Formulary Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Formulary Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Formulary Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Formulary Management include First Databank, Evernorth Health, Wolters Kluwer, McKesson, Salesforce, Pharmacy Purchasing & Products, VativoRx, Nuwae and MedReb8, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Formulary Management, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Formulary Management, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Formulary Management, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Formulary Management revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Formulary Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Formulary Management revenue, projected growth trends, production technology, application and end-user industry.

Drug Formulary Management Segment by Company

First Databank

Evernorth Health

Wolters Kluwer

McKesson

Salesforce

Pharmacy Purchasing & Products

VativoRx

Nuwae

MedReb8

Drug Formulary Management Segment by Type

Open Formulary

Closed Formulary

Drug Formulary Management Segment by Application

Hospital

Managed Care Organization (MCO)

Others

Drug Formulary Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Formulary Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Formulary Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Formulary Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Formulary Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Formulary Management company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Formulary Management revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Formulary Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Open Formulary Major Player Table 3. Closed Formulary Major Player Table 4. Global Drug Formulary Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Managed Care Organization (MCO) Major Player Table 7. Others Major Player Table 8. Drug Formulary Management Industry Trends Table 9. Drug Formulary Management Industry Drivers Table 10. Drug Formulary Management Industry Opportunities and Challenges Table 11. Drug Formulary Management Industry Restraints Table 12. Global Drug Formulary Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Drug Formulary Management Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Drug Formulary Management Market Share by Region (2021-2026) Table 15. Global Drug Formulary Management Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Drug Formulary Management Market Share by Region (2027-2032) Table 17. Global Drug Formulary Management Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Drug Formulary Management Revenue Market Share by Players (2021-2026) Table 19. Global Drug Formulary Management Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Drug Formulary Management Key Players Headquarters & Area Served Table 21. Global Drug Formulary Management Players, Product Type & Application Table 22. Global Drug Formulary Management Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Drug Formulary Management by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Drug Formulary Management Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drug Formulary Management Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Drug Formulary Management Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Drug Formulary Management Revenue Market Share by Type (2021-2026) Table 29. Global Drug Formulary Management Revenue Market Share by Type (2027-2032) Table 30. Global Drug Formulary Management Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Drug Formulary Management Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Drug Formulary Management Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Drug Formulary Management Revenue Market Share by Application (2021-2026) Table 34. Global Drug Formulary Management Revenue Market Share by Application (2027-2032) Table 35. First Databank Company Information Table 36. First Databank Business Overview Table 37. First Databank Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. First Databank Drug Formulary Management Product Portfolio Table 39. First Databank Recent Development Table 40. Evernorth Health Company Information Table 41. Evernorth Health Business Overview Table 42. Evernorth Health Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Evernorth Health Drug Formulary Management Product Portfolio Table 44. Evernorth Health Recent Development Table 45. Wolters Kluwer Company Information Table 46. Wolters Kluwer Business Overview Table 47. Wolters Kluwer Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Wolters Kluwer Drug Formulary Management Product Portfolio Table 49. Wolters Kluwer Recent Development Table 50. McKesson Company Information Table 51. McKesson Business Overview Table 52. McKesson Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. McKesson Drug Formulary Management Product Portfolio Table 54. McKesson Recent Development Table 55. Salesforce Company Information Table 56. Salesforce Business Overview Table 57. Salesforce Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Salesforce Drug Formulary Management Product Portfolio Table 59. Salesforce Recent Development Table 60. Pharmacy Purchasing & Products Company Information Table 61. Pharmacy Purchasing & Products Business Overview Table 62. Pharmacy Purchasing & Products Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Pharmacy Purchasing & Products Drug Formulary Management Product Portfolio Table 64. Pharmacy Purchasing & Products Recent Development Table 65. VativoRx Company Information Table 66. VativoRx Business Overview Table 67. VativoRx Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. VativoRx Drug Formulary Management Product Portfolio Table 69. VativoRx Recent Development Table 70. Nuwae Company Information Table 71. Nuwae Business Overview Table 72. Nuwae Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Nuwae Drug Formulary Management Product Portfolio Table 74. Nuwae Recent Development Table 75. MedReb8 Company Information Table 76. MedReb8 Business Overview Table 77. MedReb8 Drug Formulary Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. MedReb8 Drug Formulary Management Product Portfolio Table 79. MedReb8 Recent Development Table 80. North America Drug Formulary Management Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Drug Formulary Management Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Drug Formulary Management Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Drug Formulary Management Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Drug Formulary Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Drug Formulary Management Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Drug Formulary Management Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Drug Formulary Management Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Drug Formulary Management Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Drug Formulary Management Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Drug Formulary Management Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Drug Formulary Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Drug Formulary Management Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Drug Formulary Management Revenue by Country (US$ Million) & (2027-2032) Table 94. China Drug Formulary Management Revenue by Type (2021-2026) & (US$ Million) Table 95. China Drug Formulary Management Revenue by Type (2027-2032) & (US$ Million) Table 96. China Drug Formulary Management Revenue by Application (2021-2026) & (US$ Million) Table 97. China Drug Formulary Management Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Drug Formulary Management Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Drug Formulary Management Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Drug Formulary Management Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Drug Formulary Management Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Drug Formulary Management Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Drug Formulary Management Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Drug Formulary Management Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Drug Formulary Management Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Drug Formulary Management Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Drug Formulary Management Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Drug Formulary Management Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Drug Formulary Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Drug Formulary Management Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Drug Formulary Management Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Drug Formulary Management Image Figure 2. Global Drug Formulary Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Formulary Management Market Size Share 2021 VS 2025 VS 2032 Figure 4. Open Formulary Image Figure 5. Closed Formulary Image Figure 6. Global Drug Formulary Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Drug Formulary Management Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Managed Care Organization (MCO) Image Figure 10. Others Image Figure 11. Global Drug Formulary Management Market Size (US$ Million) & (2021-2032) Figure 12. Global Drug Formulary Management Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Drug Formulary Management Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Drug Formulary Management Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Drug Formulary Management Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Drug Formulary Management Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Drug Formulary Management Revenue Market Share by Type (2021-2032) Figure 19. Global Drug Formulary Management Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Drug Formulary Management Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Drug Formulary Management Revenue Market Share by Application (2021-2032) Figure 22. North America Drug Formulary Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Drug Formulary Management Revenue Share by Type (2021-2032) Figure 24. North America Drug Formulary Management Revenue Share by Application (2021-2032) Figure 25. North America Drug Formulary Management Revenue Share by Country (2021-2032) Figure 26. United States Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Drug Formulary Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Drug Formulary Management Revenue Share by Type (2021-2032) Figure 31. Europe Drug Formulary Management Revenue Share by Application (2021-2032) Figure 32. Europe Drug Formulary Management Revenue Share by Country (2021-2032) Figure 33. Germany Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Drug Formulary Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Drug Formulary Management Revenue Share by Type (2021-2032) Figure 43. China Drug Formulary Management Revenue Share by Application (2021-2032) Figure 44. Asia Drug Formulary Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Drug Formulary Management Revenue Share by Type (2021-2032) Figure 46. Asia Drug Formulary Management Revenue Share by Application (2021-2032) Figure 47. Asia Drug Formulary Management Revenue Share by Region (2021-2032) Figure 48. Japan Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Drug Formulary Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Drug Formulary Management Revenue Share by Type (2021-2032) Figure 56. SAMEA Drug Formulary Management Revenue Share by Application (2021-2032) Figure 57. SAMEA Drug Formulary Management Revenue Share by Country (2021-2032) Figure 58. Brazil Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Drug Formulary Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Open Formulary
  • Closed Formulary
Applications
  • Hospital
  • Managed Care Organization (MCO)
  • Others
Companies covered
  • First Databank
  • Evernorth Health
  • Wolters Kluwer
  • McKesson
  • Salesforce
  • Pharmacy Purchasing & Products
  • VativoRx
  • Nuwae
  • MedReb8

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Formulary Management Market by Type
  3. 1.2.1 Global Drug Formulary Management Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Open Formulary
  5. 1.2.3 Closed Formulary
  6. 1.3 Drug Formulary Management Market by Application
  7. 1.3.1 Global Drug Formulary Management Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Managed Care Organization (MCO)
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Drug Formulary Management Market Dynamics
  1. 2.1 Drug Formulary Management Industry Trends
  2. 2.2 Drug Formulary Management Industry Drivers
  3. 2.3 Drug Formulary Management Industry Opportunities and Challenges
  4. 2.4 Drug Formulary Management Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Formulary Management Market Perspective (2021-2032)
  2. 3.2 Global Drug Formulary Management Growth Trends by Region
  3. 3.2.1 Global Drug Formulary Management Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Formulary Management Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Formulary Management Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Formulary Management Revenue by Players
  2. 4.1.1 Global Drug Formulary Management Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Formulary Management Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Formulary Management Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Formulary Management Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Formulary Management Key Players Headquarters & Area Served
  7. 4.4 Global Drug Formulary Management Players, Product Type & Application
  8. 4.5 Global Drug Formulary Management Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Formulary Management Market CR5 and HHI
  11. 4.6.3 2025 Drug Formulary Management Tier 1, Tier 2, and Tier 3
5 Drug Formulary Management Market Size by Type
  1. 5.1 Global Drug Formulary Management Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Formulary Management Revenue by Type (2021-2032)
  3. 5.3 Global Drug Formulary Management Revenue Market Share by Type (2021-2032)
6 Drug Formulary Management Market Size by Application
  1. 6.1 Global Drug Formulary Management Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Formulary Management Revenue by Application (2021-2032)
  3. 6.3 Global Drug Formulary Management Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 First Databank
  2. 7.1.1 First Databank Company Information
  3. 7.1.2 First Databank Business Overview
  4. 7.1.3 First Databank Drug Formulary Management Revenue and Gross Margin (2021-2026)
  5. 7.1.4 First Databank Drug Formulary Management Product Portfolio
  6. 7.1.5 First Databank Recent Developments
  7. 7.2 Evernorth Health
  8. 7.2.1 Evernorth Health Company Information
  9. 7.2.2 Evernorth Health Business Overview
  10. 7.2.3 Evernorth Health Drug Formulary Management Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Evernorth Health Drug Formulary Management Product Portfolio
  12. 7.2.5 Evernorth Health Recent Developments
  13. 7.3 Wolters Kluwer
  14. 7.3.1 Wolters Kluwer Company Information
  15. 7.3.2 Wolters Kluwer Business Overview
  16. 7.3.3 Wolters Kluwer Drug Formulary Management Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Wolters Kluwer Drug Formulary Management Product Portfolio
  18. 7.3.5 Wolters Kluwer Recent Developments
  19. 7.4 McKesson
  20. 7.4.1 McKesson Company Information
  21. 7.4.2 McKesson Business Overview
  22. 7.4.3 McKesson Drug Formulary Management Revenue and Gross Margin (2021-2026)
  23. 7.4.4 McKesson Drug Formulary Management Product Portfolio
  24. 7.4.5 McKesson Recent Developments
  25. 7.5 Salesforce
  26. 7.5.1 Salesforce Company Information
  27. 7.5.2 Salesforce Business Overview
  28. 7.5.3 Salesforce Drug Formulary Management Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Salesforce Drug Formulary Management Product Portfolio
  30. 7.5.5 Salesforce Recent Developments
  31. 7.6 Pharmacy Purchasing & Products
  32. 7.6.1 Pharmacy Purchasing & Products Company Information
  33. 7.6.2 Pharmacy Purchasing & Products Business Overview
  34. 7.6.3 Pharmacy Purchasing & Products Drug Formulary Management Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pharmacy Purchasing & Products Drug Formulary Management Product Portfolio
  36. 7.6.5 Pharmacy Purchasing & Products Recent Developments
  37. 7.7 VativoRx
  38. 7.7.1 VativoRx Company Information
  39. 7.7.2 VativoRx Business Overview
  40. 7.7.3 VativoRx Drug Formulary Management Revenue and Gross Margin (2021-2026)
  41. 7.7.4 VativoRx Drug Formulary Management Product Portfolio
  42. 7.7.5 VativoRx Recent Developments
  43. 7.8 Nuwae
  44. 7.8.1 Nuwae Company Information
  45. 7.8.2 Nuwae Business Overview
  46. 7.8.3 Nuwae Drug Formulary Management Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Nuwae Drug Formulary Management Product Portfolio
  48. 7.8.5 Nuwae Recent Developments
  49. 7.9 MedReb8
  50. 7.9.1 MedReb8 Company Information
  51. 7.9.2 MedReb8 Business Overview
  52. 7.9.3 MedReb8 Drug Formulary Management Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MedReb8 Drug Formulary Management Product Portfolio
  54. 7.9.5 MedReb8 Recent Developments
8 North America
  1. 8.1 North America Drug Formulary Management Revenue (2021-2032)
  2. 8.2 North America Drug Formulary Management Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Formulary Management Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Formulary Management Revenue by Type (2027-2032)
  5. 8.3 North America Drug Formulary Management Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Formulary Management Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Formulary Management Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Formulary Management Revenue by Application (2027-2032)
  9. 8.5 North America Drug Formulary Management Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Formulary Management Revenue by Country
  11. 8.6.1 North America Drug Formulary Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Formulary Management Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Formulary Management Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Formulary Management Revenue (2021-2032)
  2. 9.2 Europe Drug Formulary Management Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Formulary Management Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Formulary Management Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Formulary Management Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Formulary Management Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Formulary Management Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Formulary Management Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Formulary Management Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Formulary Management Revenue by Country
  11. 9.6.1 Europe Drug Formulary Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Formulary Management Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Formulary Management Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Formulary Management Revenue (2021-2032)
  2. 10.2 China Drug Formulary Management Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Formulary Management Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Formulary Management Revenue by Type (2027-2032)
  5. 10.3 China Drug Formulary Management Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Formulary Management Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Formulary Management Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Formulary Management Revenue by Application (2027-2032)
  9. 10.5 China Drug Formulary Management Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Formulary Management Revenue (2021-2032)
  2. 11.2 Asia Drug Formulary Management Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Formulary Management Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Formulary Management Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Formulary Management Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Formulary Management Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Formulary Management Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Formulary Management Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Formulary Management Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Formulary Management Revenue by Country
  11. 11.6.1 Asia Drug Formulary Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Formulary Management Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Formulary Management Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Formulary Management Revenue (2021-2032)
  2. 12.2 SAMEA Drug Formulary Management Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Formulary Management Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Formulary Management Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Formulary Management Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Formulary Management Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Formulary Management Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Formulary Management Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Formulary Management Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Formulary Management Revenue by Country
  11. 12.6.1 SAMEA Drug Formulary Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Formulary Management Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Formulary Management Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst